Literature DB >> 12578418

Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database.

Justin B Dimick1, John A Cowan, James A Knol, Gilbert R Upchurch.   

Abstract

BACKGROUND: Hepatic resection has become common in the United States for both primary and secondary hepatic tumors. HYPOTHESIS: Variation in outcomes after hepatic resection is related to patient characteristics, the indication for operation, and hospital procedural volume.
DESIGN: Observational study using a nationally representative database. PATIENTS: All patients in the Nationwide Inpatient Sample for 1996 and 1997 with a primary procedure code for hepatic resection (N = 2097). MAIN OUTCOME MEASURES: Outcomes included in-hospital mortality and length of stay. Risk-adjusted analyses were performed using hierarchical multivariate models.
RESULTS: Overall mortality for the 2097 patients was 5.8%. The most common indications for hepatic resection were secondary metastases (52%), primary hepatic malignancy (16%), biliary tract malignancy (10%), and benign hepatic tumor (5%). High-volume hospitals had a mortality rate of 3.9% vs 7.6% at low-volume hospitals (P<.001). In the multivariate analysis adjusting for patient case-mix, high-volume hospitals had a 40% lower risk of in-hospital mortality compared with low-volume hospitals (odds ratio, 0.60; 95% confidence interval, 0.39-0.92; P =.02). Other predictors of mortality in the multivariate analysis included age older than 65 years, hepatic lobectomy (vs wedge resection), primary hepatic malignancy (vs metastases), and the severity of underlying liver disease.
CONCLUSIONS: Hospital procedural volume is an important predictor of mortality after hepatic resection. Patients who require resection of primary and secondary liver tumors should be offered referral to a high-volume center.

Entities:  

Mesh:

Year:  2003        PMID: 12578418     DOI: 10.1001/archsurg.138.2.185

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  73 in total

1.  Body mass index and adverse perioperative outcomes following hepatic resection.

Authors:  Amit K Mathur; Amir A Ghaferi; Nicholas H Osborne; Timothy M Pawlik; Darrell A Campbell; Michael J Englesbe; Theodore H Welling
Journal:  J Gastrointest Surg       Date:  2010-06-08       Impact factor: 3.452

Review 2.  Outcomes in oncologic surgery: does volume make a difference?

Authors:  David J Bentrem; Murray F Brennan
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

3.  Guidelines for resection of colorectal cancer liver metastases.

Authors:  O J Garden; M Rees; G J Poston; D Mirza; M Saunders; J Ledermann; J N Primrose; R W Parks
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

4.  Perioperative parenteral tranexamic acid in liver tumor resection: a prospective randomized trial toward a "blood transfusion"-free hepatectomy.

Authors:  Cheng-Chung Wu; Wai-Meng Ho; Shao-Bin Cheng; Dah-Cherng Yeh; Mei-Chin Wen; Tse-Jia Liu; Fang-Ku P'eng
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

5.  Surgical specialization and operative mortality in hepato-pancreatico-biliary (HPB) surgery.

Authors:  Nicholas G Csikesz; Jessica P Simons; Jennifer F Tseng; Shimul A Shah
Journal:  J Gastrointest Surg       Date:  2008-07-09       Impact factor: 3.452

6.  Racial disparity in surgical mortality after major hepatectomy.

Authors:  Hari Nathan; Wayne Frederick; Michael A Choti; Richard D Schulick; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2008-06-02       Impact factor: 6.113

7.  Population-based review of the outcomes following hepatic resection in a Canadian health region.

Authors:  Elijah Dixon; Oliver F Bathe; Andrew McKay; Isabelle You; Scot Dowden; David Sadler; Kelly W Burak; J Gregory McKinnon; Walter Miller; Francis R Sutherland
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

8.  Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy.

Authors:  Christopher Christophi; Mehrdad Nikfarjam; Caterina Malcontenti-Wilson; Vijayaragavan Muralidharan
Journal:  World J Surg       Date:  2004-09-29       Impact factor: 3.352

9.  Regionalization and outcomes of hepato-pancreato-biliary cancer surgery in USA.

Authors:  Paul D Colavita; Victor B Tsirline; Igor Belyansky; Ryan Z Swan; Amanda L Walters; Amy E Lincourt; David A Iannitti; B Todd Heniford
Journal:  J Gastrointest Surg       Date:  2014-01-16       Impact factor: 3.452

10.  Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database.

Authors:  Ronnie T Poon; Sheung Tat Fan; Chung Mau Lo; Chi Leung Liu; Chi Ming Lam; Wai Key Yuen; Chun Yeung; John Wong
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.